Schedule 13G ownership disclosure

Korro Bio Inc

Common Stock, par value $0.001 per share · CUSIP: 500946108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 540,074.00 · Class: 5.8%

  • Point72 Capital Advisors, Inc.

    Shares: 540,074.00 · Class: 5.8%

  • Point72 Biotech Private Investments, LLC

    Shares: 276,831.00 · Class: 2.9%

  • Differentiated Ventures Investments, LLC

    Shares: 276,831.00 · Class: 2.9%

  • 72 Investment Holdings, LLC

    Shares: 276,831.00 · Class: 2.9%

  • Steven A. Cohen

    Shares: 816,905.00 · Class: 8.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003690
Form type
SCHEDULE 13G/A
Filer
Korro Bio, Inc.
CIK
CIK 1703647
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub